Wednesday, September 15, 2010
New Diet Drug Faces U.S. Advisers Amid Risk Debate
ADELPHI, Maryland - Arena Pharmaceuticals Inc faces a pivotal test on Thursday as U.S. government advisers consider whether to back the company's weight-loss pill amid questions about tumors in rats and other health problems reported in studies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment